Skip to main content
SpringerLink
Log in

Role of Enzymatic Lability in the Corneal and Conjunctival Penetration of Timolol Ester Prodrugs in the Pigmented Rabbit

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The main objective of this study was to investigate how enzymatic lability would affect the extent of corneal and conjunctival penetration of a series of alkyl, cycloalkyl, and aryl ester prodrugs of timolol in the pigmented rabbit. Enzymatic lability of the prodrugs was studied in corneal epithelial and conjunctival homogenates, while their corneal and conjunctival penetration was determined using the isolated tissues in the modified Ussing chamber. The straight-chain alkyl and the unsubstituted cycloalkyl esters were hydrolyzed more rapidly than their corresponding branched-chain and substituted analogues as well as the aryl esters. The corneal and conjunctival penetration of all prodrugs, regardless of enzymatic lability, varied parabolically with lipophilicity. Moreover, the enzymatically more labile straight-chain alkyl esters penetrated the cornea and the conjunctiva more readily than the more stable branched-chain esters of comparable lipophilicity. Enzymatic lability is, therefore, an additional factor that should be considered in designing alkyl ester prodrugs with improved ocular drug delivery characteristics. Enzymatic lability does not, however, play as important a role as lipophilicity in the corneal and conjunctival penetration of cycloalkyl and aryl ester prodrugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. W. L. Nelson, F. L. Fraunfelder, J. M. Sills, J. B. Arrowsmith, and J. N. Kuritsky. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978–1985. Am. J. Ophthalmol. 102:606–611 (1986).

    Google Scholar 

  2. S. C. Chang, H. Bundgaard, A. Buur, and V. H. L. Lee. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest. Ophthalmol. Vis. Sci. 28:487–491 (1987).

    Google Scholar 

  3. S. C. Chang, H. Bundgaard, A. Buur, and V. H. L. Lee. Low dose O-butyryl timolol improves the therapeutic index of timolol in the pigmented rabbit. Invest. Ophthalmol. Vis. Sci. 29:626–629 (1988).

    Google Scholar 

  4. H. Bundgaard, A. Buur, S. C. Chang, and V. H. L. Lee. Timolol prodrugs: Synthesis, stability and lipophilicity of various alkyl, cycloalkyl, and aromatic esters of timolol. Int. J. Pharm. 46:77–88 (1988).

    Google Scholar 

  5. S. C. Chang, D. S. Chien, H. Bundgaard, and V. H. L. Lee. Relative effectiveness of prodrug and viscous solution approaches in maximizing the the ratio of ocular to systemic absorption of topically applied timolol. Exp. Eye Res. 46:59–69 (1988).

    Google Scholar 

  6. S. C. Chang and V. H. L. Lee. Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: Implications in the design of strategies to maximize the ratio of ocular to systemic absorption. J. Ocular Pharmacol. 3:159–169 (1987).

    Google Scholar 

  7. M. G. Doane, A. D. Jensen, and C. H. Dohlman. Penetration routes of topically applied eye medications. Am. J. Ophthalmol. 85:383–386 (1978).

    Google Scholar 

  8. H. Bundgaard, A. Buur, and V. H. L. Lee. Timolol prodrugs: Preparation and hydrolysis kinetics of N-benzoyl carbamate esters of timolol and related compounds. Acta Pharm. Suec. 25:293–306 (1988).

    Google Scholar 

  9. V. H. L. Lee, D. S. Chien, and H. Sasaki. Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit. J. Pharmacol. Exp. Ther. 246:871–878 (1988).

    Google Scholar 

  10. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254 (1976).

    Article  CAS  PubMed  Google Scholar 

  11. H. F. Edelhauser, J. R. Hoffert, and P. O. Fromm. In vitro ion and water movement in corneas of rainbow trout. Invest. Ophthalmol. 4:290–296 (1965).

    Google Scholar 

  12. D. S. Chien, H. Bundgaard, and V. H. L. Lee. Influence of corneal epithelial integrity on the penetration of timolol prodrugs. J. Ocular Pharmacol. 4:137–145 (1988).

    Google Scholar 

  13. R. D. Schoenwald and R. L. Ward. Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients. J. Pharm. Sci. 67:786–788 (1978).

    Google Scholar 

  14. G. L. Mosher and T. J. Mikkelson. Permeability of the n-alkyl p-aminobenzoate esters across the isolated corneal membrane of the rabbit. Int. J. Pharm. 2:239–243 (1979).

    Google Scholar 

  15. K. Kishida and T. Otori. A quantitative study on the relationship between transcorneal permeability of drugs and their hydrophobicity. Jpn. J. Ophthalmol. 24:251–259 (1980).

    Google Scholar 

  16. R. D. Schoenwald and H. S. Huang. Corneal penetration behavior of β-blocking agents. I. Physicochemical factors. J. Pharm. Sci. 72:1266–1272 (1983).

    Google Scholar 

  17. G. M. Grass and J. R. Robinson. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability. J. Pharm. Sci. 73:1021–1027 (1984).

    Google Scholar 

  18. R. O. Potts, S. C. McNeill, C. R. Desbonnet, and E. Wakshull. Transdermal drug transport and metabolism. II. The role of competing kinetic events. Pharm. Res. 6:119–124 (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, Department of Pharmaceutical Sciences, University of Southern California, 1985 Zonal Avenue, Los Angeles, California, 90033

    Du-Shieng Chien, Hitoshi Sasaki, Hans Bundgaard, Anders Buur & Vincent H. L. Lee

  2. Allergan Pharmaceuticals, Department of Pharmacokinetics and Drug Metabolism, 2525 Dupont Drive, Irvine, California, 92715

    Du-Shieng Chien

  3. Faculty of Pharmaceutical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki, 852, Japan

    Hitoshi Sasaki

  4. Royal Danish School of Pharmacy, Department of Pharmaceutical Chemistry, 2 Universitetsparken, Copenhagen, DK-2100, Denmark

    Hans Bundgaard & Anders Buur

Authors
  1. Du-Shieng Chien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hitoshi Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Bundgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anders Buur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincent H. L. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chien, DS., Sasaki, H., Bundgaard, H. et al. Role of Enzymatic Lability in the Corneal and Conjunctival Penetration of Timolol Ester Prodrugs in the Pigmented Rabbit. Pharm Res 8, 728–733 (1991). https://doi.org/10.1023/A:1015845916293

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015845916293

Search

Navigation